Marta Miarons

9PUBLICATIONS
29CO-AUTHORS
Aboriginal and Torres Strait Islander genomicsPredictive and prognostic markersInfant and child healthRadiation therapyPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 28, 2026
Impact of UGT1A1*28 Allele on the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence.

Fernando do Pazo-Oubiña, Betel Del Rosario García, Marta Miarons

|Jul 28, 2025
A machine learning model exploring the relationship between chronic medication and COVID-19 clinical outcomes.

Berta Miró, Natalia Díaz González, Juan-Francisco Martínez-Cerdá

|Jan 08, 2025
Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study.

Susana Clemente Bautista, Óscar Segarra Cantón, Núria Padullés-Zamora

|Jan 17, 2024
Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy?

Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Troconiz

|Apr 04, 2023
Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study.

Marta Miarons, Alba Manzaneque Gordón, Pau Riera

|Jul 27, 2022
Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study.

Cristina Aguilera, Immaculada Danés, Elena Guillén

Pageof 2